Brazil receives vaccine cargo from India amid supply concernThe 2 million doses from India only scratch the surface of the shortfall, Brazilian public health experts told, as far more doses will be n...
Growing uncertainty over efficacy of China made SinovacThe Sinovac allegedly has shown four different efficacy rates during clinical trials ranging from over 91 to 50 per cent. The global scient...
Turkey approves China-based Sinovac vaccine's emergency useThe country's health minister and members of the country's scientific advisory council received the first shots live on television, soon af...
China’s struggling to get the world to trust its vaccinesThat mistrust, and the reliance of dozens of poorer nations on China to inoculate their populations could set the stage for a major global ...
Brazil drug agency questions 'transparency' of China vaccineThe Brazilian health regulator Anvisa on Monday accused China of using criteria that "are not transparent" to win emergency approval of its...
Halted Brazil trials of Chinese-made coronavirus vaccine cause surpriseThe potential vaccine is being developed by Chinese biopharmaceutical firm Sinovac and in Brazil would be mostly produced by Sao Paulo's st...
Brazil suspends Sinovac COVID-19 vaccine trial due to adverse eventThe health regulator, Anvisa, said on Monday the event took place on Oct. 29 but did not specify if the incident took place in Brazil or in...
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueThe Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said the volunteer was Brazi...
Brazil tests covid-19 shot, without deal to use it if it worksBrazil is testing an experimental coronavirus vaccine, but interim Health Minister Eduardo Pazuello acknowledged Tuesday that the governmen...
New spider species named after 'Harry Potter' characters'The Lord of the Rings' and other literary classics also inspired the names of small cave-dwelling six-eyed spiders inhabiting in northern ...
Mylan-Biocon's breast cancer biosimilar gets ANVISA nodBiosimilar trastuzumab, indicated for breast cancer treatment, has been co-developed by Biocon and Mylan.